首页> 外文OA文献 >Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn’s Disease Patient Successfully Treated with Ustekinumab

【2h】

Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn’s Disease Patient Successfully Treated with Ustekinumab

机译：肿瘤坏死因子抑制剂诱导儿科克罗恩病患者的牛皮癣成功用Ustekinubab治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lauren Bonomo; Ellen de Moll; Linden Li; Lauren Geller; Michael Gordon; David Dunkin;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn's Disease Patient Successfully Treated with Ustekinumab [J] . Bonomo Lauren, de Moll Ellen H., Li Linden., Journal of drugs in dermatology: JDD . 2020,第3期

机译：肿瘤坏死因子抑制剂诱导的儿科克罗恩病患者的牛皮癣成功用Ustekuinubab治疗
2. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti–Tumor Necrosis Factor Alpha Agents [J] . Eickstaedt Joshua B., Killpack Luke, Tung Jeanne, Pediatric dermatology . 2017,第S1期

机译：用抗肿瘤坏死因子α药剂治疗炎症性肠病患者的牛皮癣和牛皮癣爆发
3. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents [J] . Eickstaedt Joshua B., Killpack Luke, Tung Jeanne, Pediatric dermatology . 2017,第3期

机译：用抗肿瘤坏死因子α药剂治疗炎症性肠病患者的牛皮癣和牛皮癣爆发
4. Additive Effects of Simvastatin and Ranripril on Inflammatory Cytokines Interferon-y, Tumor Necrosis Factor-a, Interleukin-6 and C-Reactive Protein in Diabetic Patients with Hyperlipidemia and Coronary Artery Disease [C] . L. Tan, S. Tan, L. Berk, International Congress on Coronary Artery Disease . 2003

机译：辛伐他汀和RanRipril对糖尿病患者患者高脂血症和冠状动脉疾病炎症细胞因子干扰素-Y，肿瘤坏死因子-A，白细胞介素-6和C反应蛋白的添加剂效应
5. Biolo?ki Procesi in Napovedovanje Neodzivnosti Na Zaviralce Dejavnika Tumorske Nekroze Pri Crohnovi Bolezni z Integracijo Genomskih Podatkov =Biological processes and predicting non-response to tumor necrosis factor inhibitors in Crohn's disease by integr [D] . Jezernik, Gregor. 2021

机译：通过整合基因组数据=生物学过程和预测携带基因组疾病肿瘤疾病肿瘤坏死因子抑制剂的生物过程和预测性
6. Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist [O] . Przemysław Holko, Paweł Kawalec, Andrzej Pilc -1

机译：Vedolizumab和Ustekinumab治疗肿瘤坏死因子-α拮抗剂失败后克罗恩病的成本-效果分析
7. Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents [O] . Wils Pauline, Bouhnik Yoram, Michetti Pierre, 2016

机译：皮下乌斯他单抗为三分之二抗肿瘤坏死因子难治性克罗恩病患者提供临床益处

Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn’s Disease Patient Successfully Treated with Ustekinumab

著录项

引文网络

相似文献

相关主题

期刊订阅